Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Laboratories (CLB) Other financing activities (2022 - 2025)

Core Laboratories (CLB) has 4 years of Other financing activities data on record, last reported at -$5.0 million in Q3 2025.

  • For Q3 2025, Other financing activities fell 942.53% year-over-year to -$5.0 million; the TTM value through Sep 2025 reached -$236000.0, up 94.28%, while the annual FY2024 figure was $19000.0, 99.53% down from the prior year.
  • Other financing activities reached -$5.0 million in Q3 2025 per CLB's latest filing, down from $538000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $9.9 million in Q3 2023 and bottomed at -$8.3 million in Q4 2023.
  • Average Other financing activities over 4 years is $1.3 million, with a median of $538000.0 recorded in 2025.
  • The widest YoY moves for Other financing activities: up 21789.47% in 2025, down 942.53% in 2025.
  • A 4-year view of Other financing activities shows it stood at $2.2 million in 2022, then crashed by 473.23% to -$8.3 million in 2023, then surged by 100.23% to $19000.0 in 2024, then crashed by 26163.16% to -$5.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other financing activities were -$5.0 million in Q3 2025, $538000.0 in Q2 2025, and $4.2 million in Q1 2025.